Fate Therapeutics, Inc.'s (FATE) CEO Scott Wolchko on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/08/19
Fate Therapeutics (FATE) Reports Q1 Loss, Misses Revenue EstimatesZacks Investment Research • 05/07/19